Avacta Group Plc (AVCTF)
USD 0.52
(-16.56%)
USD 0.52
(-16.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 23.12 Million GBP | -3.0% |
| 2022 | 23.84 Million GBP | 1300.06% |
| 2021 | 1.7 Million GBP | -16.6% |
| 2020 | 2.04 Million GBP | 148.12% |
| 2019 | 823 Thousand GBP | 0.0% |
| 2018 | - GBP | 0.0% |
| 2017 | - GBP | 0.0% |
| 2016 | - GBP | 0.0% |
| 2015 | - GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| 2013 | - GBP | 0.0% |
| 2012 | - GBP | -100.0% |
| 2011 | 4000.00 GBP | -75.0% |
| 2010 | 16 Thousand GBP | -44.83% |
| 2009 | 29 Thousand GBP | -29.27% |
| 2008 | 41 Thousand GBP | -21.15% |
| 2007 | 52 Thousand GBP | 5100.0% |
| 2006 | 1000.00 GBP | -99.2% |
| 2005 | 125 Thousand GBP | -56.14% |
| 2004 | 285 Thousand GBP | -12.04% |
| 2003 | 324 Thousand GBP | -51.5% |
| 2002 | 668 Thousand GBP | 21.01% |
| 2001 | 552 Thousand GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 22.35 Million GBP | -55.17% |
| 2023 Q3 | 40.54 Million GBP | 81.38% |
| 2023 FY | 23.12 Million GBP | -3.0% |
| 2023 Q4 | 23.12 Million GBP | -42.95% |
| 2023 Q1 | 49.85 Million GBP | 109.11% |
| 2022 Q4 | 23.84 Million GBP | -61.28% |
| 2022 FY | 23.84 Million GBP | 1300.06% |
| 2022 Q1 | 3.97 Million GBP | 133.29% |
| 2022 Q2 | 4.83 Million GBP | 21.57% |
| 2022 Q3 | 61.58 Million GBP | 1174.99% |
| 2021 Q3 | 1.41 Million GBP | -25.65% |
| 2021 Q4 | 1.7 Million GBP | 20.61% |
| 2021 FY | 1.7 Million GBP | -16.6% |
| 2021 Q1 | 1.59 Million GBP | -21.69% |
| 2021 Q2 | 1.89 Million GBP | 18.76% |
| 2020 Q3 | 1.75 Million GBP | 139.34% |
| 2020 Q1 | 568 Thousand GBP | 0.0% |
| 2020 Q2 | 732 Thousand GBP | 28.87% |
| 2020 Q4 | 2.04 Million GBP | 16.55% |
| 2020 FY | 2.04 Million GBP | 148.12% |
| 2019 FY | 823 Thousand GBP | 0.0% |
| 2019 Q1 | - GBP | 0.0% |
| 2019 Q2 | - GBP | 0.0% |
| 2018 Q4 | - GBP | 0.0% |
| 2018 FY | - GBP | 0.0% |
| 2018 Q2 | - GBP | 0.0% |
| 2018 Q1 | - GBP | 0.0% |
| 2017 Q1 | - GBP | 0.0% |
| 2017 FY | - GBP | 0.0% |
| 2017 Q4 | - GBP | 0.0% |
| 2017 Q3 | - GBP | 0.0% |
| 2017 Q2 | - GBP | 0.0% |
| 2016 Q1 | - GBP | 0.0% |
| 2016 FY | - GBP | 0.0% |
| 2016 Q3 | - GBP | 0.0% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2015 FY | - GBP | 0.0% |
| 2015 Q3 | - GBP | 0.0% |
| 2015 Q1 | - GBP | 0.0% |
| 2015 Q2 | - GBP | 0.0% |
| 2015 Q4 | - GBP | 0.0% |
| 2014 Q3 | - GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| 2014 Q1 | - GBP | 0.0% |
| 2014 Q2 | - GBP | 0.0% |
| 2014 Q4 | - GBP | 0.0% |
| 2013 Q4 | - GBP | 0.0% |
| 2013 Q1 | - GBP | 0.0% |
| 2013 Q2 | - GBP | 0.0% |
| 2013 FY | - GBP | 0.0% |
| 2013 Q3 | - GBP | 0.0% |
| 2012 Q4 | - GBP | 0.0% |
| 2012 Q2 | - GBP | 0.0% |
| 2012 Q3 | - GBP | 0.0% |
| 2012 FY | - GBP | -100.0% |
| 2011 FY | 4000.00 GBP | -75.0% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | 4000.00 GBP | 0.0% |
| 2010 Q4 | 9000.00 GBP | 0.0% |
| 2010 Q2 | 16 Thousand GBP | 0.0% |
| 2010 FY | 16 Thousand GBP | -44.83% |
| 2009 Q4 | 22 Thousand GBP | 0.0% |
| 2009 Q2 | 29 Thousand GBP | 0.0% |
| 2009 FY | 29 Thousand GBP | -29.27% |
| 2008 FY | 41 Thousand GBP | -21.15% |
| 2008 Q4 | 285 Thousand GBP | 0.0% |
| 2008 Q2 | 41 Thousand GBP | 0.0% |
| 2007 Q4 | 47 Thousand GBP | 0.0% |
| 2007 FY | 52 Thousand GBP | 5100.0% |
| 2006 FY | 1000.00 GBP | -99.2% |
| 2006 Q1 | 1000.00 GBP | 0.0% |
| 2006 Q3 | - GBP | 0.0% |
| 2005 FY | 125 Thousand GBP | -56.14% |
| 2005 Q3 | - GBP | 0.0% |
| 2005 Q1 | 125 Thousand GBP | 0.0% |
| 2004 FY | 285 Thousand GBP | -12.04% |
| 2004 Q1 | 285 Thousand GBP | 0.0% |
| 2004 Q3 | - GBP | 0.0% |
| 2003 FY | 324 Thousand GBP | -51.5% |
| 2003 Q3 | - GBP | 0.0% |
| 2002 FY | 668 Thousand GBP | 21.01% |
| 2001 FY | 552 Thousand GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.32 Million USD | -13.774% |
| Skye Bioscience, Inc. | 4.61 Million USD | -401.12% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 22.304% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -18780.0% |
| Qrons Inc. | 351.84 Thousand USD | -6473.312% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -293.93% |
| BioStem Technologies, Inc. | 4.71 Million USD | -390.893% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2958.434% |
| CSL Limited | 12.18 Billion USD | 99.81% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 49.236% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 46.677% |
| Rebus Holdings, Inc. | 310 Thousand USD | -7360.645% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -3570.662% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -89825.736% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 43.868% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -461.093% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -5655.396% |
| SQZ Biotechnologies Company | 27.47 Million USD | 15.809% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -894.344% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -2338.965% |
| Mesoblast Limited | 118.7 Million USD | 80.516% |
| Marizyme, Inc. | 18.71 Million USD | -23.564% |
| Genus plc | 233.1 Million USD | 90.078% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -689.247% |
| Pharming Group N.V. | 171.54 Million USD | 86.518% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -2504.317% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1621.366% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -2983.733% |
| ContraFect Corporation | 2.88 Million USD | -702.777% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -16970.272% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1499.094% |
| IMV Inc. | 28.88 Million USD | 19.928% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -308.741% |
| MultiCell Technologies, Inc. | 202.58 USD | -11416624.257% |
| ONE Bio Corp. | 19.71 Million USD | -17.312% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 59.77% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -1447.281% |
| Q BioMed Inc. | 4.1 Million USD | -462.728% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 30.129% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -1782.834% |
| Biomind Labs Inc. | 735.54 Thousand USD | -3044.348% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 65.809% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -664.261% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -77.949% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -6329.624% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -16242.797% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -924.096% |
| GB Sciences, Inc. | 1.75 Million USD | -1214.609% |
| Alpha Cognition Inc. | 1.22 Million USD | -1795.16% |
| HST Global, Inc. | 98.31 Thousand USD | -23423.429% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -9198.81% |
| Halberd Corporation | 150 Thousand USD | -15318.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -2221.301% |
| Agentix Corp. | 50 Thousand USD | -46156.0% |
| Resverlogix Corp. | 6.49 Million USD | -256.309% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -8948.797% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -15.64% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -226.999% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -753.84% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -226090.709% |
| Genscript Biotech Corporation | 417.73 Million USD | 94.464% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -11428.492% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -864.581% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -9986.746% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -15458.276% |
| Kadimastem Ltd | 891.22 Thousand USD | -2495.077% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -9144.47% |
| LadRx Corporation | 33.6 Thousand USD | -68721.044% |
| Cell Source, Inc. | 9.25 Million USD | -149.92% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2958.434% |
| NovAccess Global Inc. | 2.19 Million USD | -951.33% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -10027.114% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -10862.436% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -364.138% |
| Mobile Lads Corp. | 484.28 Thousand USD | -4675.71% |
| CytoDyn Inc. | 30.07 Million USD | 23.101% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -195.756% |
| SYBLEU INC | 477.5 Thousand USD | -4743.56% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -388.419% |
| International Stem Cell Corporation | 4.17 Million USD | -453.566% |
| Bioxytran, Inc. | 1.92 Million USD | -1101.455% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -36956.382% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -960.48% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -178.114% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -169.4% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1386.873% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -8529.851% |
| Neutra Corp. | 54.15 Thousand USD | -42606.256% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -1163.825% |
| PureTech Health plc | 25.51 Million USD | 9.345% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -1789.194% |
| IXICO plc | 472.02 Thousand USD | -4799.761% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -49.203% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 62.854% |
| CSL Limited | 12.18 Billion USD | 99.81% |
| Cellectis S.A. | 92.77 Million USD | 75.071% |